Close
Back to mobile site

More on XERS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+16.7% Growth)
- Ratings (8.9 Score)
- Holders

Upcoming Events

- Earnings (5/8/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Xeris Pharmaceuticals Inc. (NQ:XERS)
Delayed: 1.76 --0 (-0%)
Prev. Close $1.76  
Open$1.76 
52 Wk High$ 
52 Wk Low$ 
Day High$1.76 
Day Low$1.76 
P/E N/A  
EPS$ 
Volume4 

Friends, Peers and Foes (?): ASRT, ALIM, AYTU EOLS (more...)

Apr 11, 2024 04:06 PM Form 4 Xeris Biopharma Holdings For: Mar 15 Filed by: SHERMAN JEFFREY W
Apr 3, 2024 04:05 PM Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Apr 2, 2024 07:00 AM Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Apr 1, 2024 05:45 PM Form 4 Xeris Biopharma Holdings For: Mar 15 Filed by: Kong Garheng
Apr 1, 2024 05:43 PM Form 4 Xeris Biopharma Holdings For: Mar 15 Filed by: JOHNSON JOHN
Mar 27, 2024 04:03 PM Oppenheimer Starts Xeris Pharmaceuticals (XERS) at Outperform, 'successful commercial execution will continue to drive top-line growth'
Mar 18, 2024 05:33 PM Form 4 Xeris Biopharma Holdings For: Mar 18 Filed by: JOHNSON JOHN
Mar 14, 2024 09:04 PM Form 4 Xeris Biopharma Holdings For: Mar 14 Filed by: Schmid John P.
Mar 7, 2024 06:39 AM Xeris Pharmaceuticals (XERS) PT Raised to $6 at H.C. Wainwright
Mar 6, 2024 04:11 PM Form 10-K Xeris Biopharma Holdings For: Dec 31
View All Articles

Entities mentioned with XERS

View All Entities